spacer
The Healthcare Sales & Marketing Network celebrates 22 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  H5N1 

 HSMN NewsFeed - 8 Jun 2020
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
Diagnostics Product Launch
 HSMN NewsFeed - 30 Apr 2019
510(k) Market Clearance for FluChip-8G Influenza A+B Assay
Diagnostics FDA
 HSMN NewsFeed - 14 May 2018
Ansun BioPharma secures $85 million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Mar 2018
Longhorn Vaccines and Diagnostics LLC receives de novo clearance by the U.S. Food and Drug Administration for PrimeStore(R) Molecular Transport Medium establishing a new class of microbial nucleic acid stabilization devices for molecular testing
Devices Diagnostics FDA
 HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 May 2015
PaxVax Appoints Nima Farzan Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Diagnostics
 HSMN NewsFeed - 7 Aug 2014
Specialty Vaccine Company PaxVax Expands Global Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2014
PaxVax Announces New Commercial Senior Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2013
PaxVax Secures $22 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Feb 2012
PaxVax Expands Executive Management Team
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 8 Sep 2011
Nexera Medical, Inc. Announces That It Plans to Submit New Data to the U.S. Food and Drug Administration (FDA) to Amend Its Current 510k Medical Device Clearance to Include Certain Strains of Viruses
Devices
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Devices Personnel
 HSMN NewsFeed - 18 Nov 2009
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
Diagnostics Oncology Distribution
 HSMN NewsFeed - 28 Sep 2009
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2009
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Devices HIV/AIDS
 HSMN NewsFeed - 11 Mar 2009
Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Devices HIV/AIDS
 HSMN NewsFeed - 21 May 2008
Aethlon Medical Announces Cancer Treatment License
Devices Licensing
 HSMN NewsFeed - 19 Feb 2008
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Feb 2008
HepaLife's Bioartificial Liver Dramatically Reduces Toxic Marker for Acute Liver Failure
Devices
 HSMN NewsFeed - 11 Feb 2008
AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
Delcath and Aethlon Medical Sign Collaboration Agreement to Research and Develop Advanced Filtration Technology
Devices Oncology
 HSMN NewsFeed - 22 Jan 2008
The Aethlon Hemopurifier(R) Proves Effective in Capturing Bird Flu Virus
Devices
 HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Oct 2007
AVI BioPharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
Biopharmaceuticals Wound Care Distribution
 HSMN NewsFeed - 26 Sep 2007
HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver
Devices Regenerative Medicine
 HSMN NewsFeed - 24 Sep 2007
MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Aug 2007
Internationally Renowned Artificial Organs Expert Joins HepaLife(TM)
Devices Personnel
 HSMN NewsFeed - 16 Aug 2007
Carrington and DaySpring Pharma Sign Term Sheet for Distribution of Diabetic and Radiation Products Into Physician Market
Biopharmaceuticals Distribution
 HSMN NewsFeed - 13 Aug 2007
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
Devices
 HSMN NewsFeed - 9 Jul 2007
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
Devices Personnel
 HSMN NewsFeed - 9 Jul 2007
Novavax Licenses Wyeth's Virus-Like Particle Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Jun 2007
Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2007
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2007
HepaLife Achieves Major Milestone in Development of Artificial Liver Device
Devices
 HSMN NewsFeed - 18 Apr 2007
Carrington and Primus Pharmaceuticals Sign Long-Term Supply and Patent Licensing Agreements for Acemannan Hydrogel(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Apr 2007
FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Mar 2007
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2007
Novavax Board of Directors Elect John Lambert as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
Biopharmaceuticals
 HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Dec 2006
Novavax Relocating Corporate Headquarters to Maryland
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2006
GlaxoSmithKline Awarded HHS Contract
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Aethlon Medical Acquires Strategic Cancer Therapy Patent
Devices Oncology
 HSMN NewsFeed - 30 Oct 2006
QIAGEN Acquires Genaco Biomedical Products, Inc.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2006
Novavax Names Dr. Penny Heaton Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2006
GSK Grants License for Manufacture of Influenza Treatment Zanamivir
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Sep 2006
Protiva Files Suit Against Inex in California Superior Court
Biopharmaceuticals Litigation
 HSMN NewsFeed - 17 Aug 2006
Novavax Names Jeffrey Church Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2006
Dr. Harold Handley Appointed President of Aethlon Medical, Inc.
Devices Personnel
 HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jun 2006
BioCryst and Green Cross Enter Agreement to Develop and Commercialize Peramivir in South Korea
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2006
Novavax Strengthens Vaccine Development Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2006
AVI BioPharma Reports Successful Inhibition of Multiple Subtypes of Influenza A Using NEUGENE Antisense Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 30 Mar 2006
GlaxoSmithKline Initiates Human Trial Program With Two H5N1 Pandemic Flu Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2006
AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases
Devices Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Feb 2006
Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2006
Aethlon Medical Announces Avian Flu Treatment Application
Devices
 HSMN NewsFeed - 25 Jan 2006
Generex Biotechnology Announces Interim Results of Clinical Breast Cancer Trials
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jan 2006
Generex Biotechnology Announces FDA Pre-IND Meeting Scheduled for the Avian Flu Vaccine
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jan 2006
BioCryst Receives FDA Fast Track Designation for Peramivir
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
H5N1
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.